SLC1A3 and psychiatric disorder: Disruption of these molecular mechanisms contributes to the development of neurological and psychiatric disorders such as autism spectrum disorder, schizophrenia, Alzheimer’s disease, and hidden hearing loss (HHL) caused by synaptopathy following GLAST-KO-induced glutamate transporter dysfunction [97].